92 related articles for article (PubMed ID: 15840385)
1. Effects of analogs of indole-3-carbinol cyclic trimerization product in human breast cancer cells.
Xue L; Schaldach CM; Janosik T; Bergman J; Bjeldanes LF
Chem Biol Interact; 2005 Apr; 152(2-3):119-29. PubMed ID: 15840385
[TBL] [Abstract][Full Text] [Related]
2. The major cyclic trimeric product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway.
Riby JE; Feng C; Chang YC; Schaldach CM; Firestone GL; Bjeldanes LF
Biochemistry; 2000 Feb; 39(5):910-8. PubMed ID: 10653634
[TBL] [Abstract][Full Text] [Related]
3. 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha.
Abdelrahim M; Ariazi E; Kim K; Khan S; Barhoumi R; Burghardt R; Liu S; Hill D; Finnell R; Wlodarczyk B; Jordan VC; Safe S
Cancer Res; 2006 Feb; 66(4):2459-67. PubMed ID: 16489053
[TBL] [Abstract][Full Text] [Related]
4. Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer.
Ashok BT; Chen YG; Liu X; Garikapaty VP; Seplowitz R; Tschorn J; Roy K; Mittelman A; Tiwari RK
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S86-93. PubMed ID: 12570340
[TBL] [Abstract][Full Text] [Related]
5. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.
Caruso JA; Campana R; Wei C; Su CH; Hanks AM; Bornmann WG; Keyomarsi K
Cell Cycle; 2014; 13(16):2587-99. PubMed ID: 25486199
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha as a target for indole-3-carbinol.
Wang TT; Milner MJ; Milner JA; Kim YS
J Nutr Biochem; 2006 Oct; 17(10):659-64. PubMed ID: 16488130
[TBL] [Abstract][Full Text] [Related]
7. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
Lin Z; Reierstad S; Huang CC; Bulun SE
Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
9. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
10. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.
Liu H; Wormke M; Safe SH; Bjeldanes LF
J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413
[TBL] [Abstract][Full Text] [Related]
11. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
12. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.
Marconett CN; Sundar SN; Poindexter KM; Stueve TR; Bjeldanes LF; Firestone GL
Mol Biol Cell; 2010 Apr; 21(7):1166-77. PubMed ID: 20130088
[TBL] [Abstract][Full Text] [Related]
14. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
Hua KT; Way TD; Lin JK
Mol Carcinog; 2006 Aug; 45(8):551-60. PubMed ID: 16637063
[TBL] [Abstract][Full Text] [Related]
15. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities.
Larrosa M; González-Sarrías A; García-Conesa MT; Tomás-Barberán FA; Espín JC
J Agric Food Chem; 2006 Mar; 54(5):1611-20. PubMed ID: 16506809
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
Gionet N; Jansson D; Mader S; Pratt MA
J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
[TBL] [Abstract][Full Text] [Related]
17. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol.
Ashok BT; Chen Y; Liu X; Bradlow HL; Mittelman A; Tiwari RK
Nutr Cancer; 2001; 41(1-2):180-7. PubMed ID: 12094623
[TBL] [Abstract][Full Text] [Related]
19. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
20. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
Woodfield GW; Horan AD; Chen Y; Weigel RJ
Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]